Neuraxis, Inc. is an innovative medical technology firm based in Versailles, Indiana, dedicated to advancing neuromodulation therapy devices aimed at treating various neurological disorders. The company leverages cutting-edge technology and rigorous research to develop therapeutic solutions that improve patient outcomes and enhance the quality of life for individuals suffering from these conditions. Neuraxis's commitment to addressing significant unmet medical needs positions it strategically for growth in the dynamic neuromodulation market, representing a compelling investment opportunity for institutional investors.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

11611 NORTH MERIDIAN ST, CARMEL, IN, UNITED STATES, 46032

December

$23.5 Million

-$7.54 Million

0.0

-1.05

$0.00

0.0%

3.164